tetano
Editor, Senior Moderator
Vaccines (Basel)
. 2020 Nov 25;8(4):E704.
doi: 10.3390/vaccines8040704.
Adjuvanted Influenza Vaccines Elicits Higher Antibody Responses against the A(H3N2) Subtype than Non-Adjuvanted Vaccines
Laura S?nchez de Prada[SUP] 1 [/SUP], Iv?n Sanz Mu?oz[SUP] 2 [/SUP], Javier Castrodeza Sanz[SUP] 1 [/SUP], Ra?l Ortiz de Lejarazu Leonardo[SUP] 2 [/SUP], Jos? Mar?a Eiros Bouza[SUP] 2 3 [/SUP]
Affiliations
Abstract
Background: vaccination is the best approach to prevent influenza infections so far. Serological studies on the effect of different vaccine types are important to address vaccination campaigns and protect our population. In our study, we compared the serological response against influenza A subtypes using the non-adjuvanted influenza vaccine (NAIV) in adults and the elderly and the adjuvanted influenza vaccine (AIV) in the elderly.
Methods: We performed a retrospective analysis by hemagglutination inhibition assay (HI) of serum samples right before and 28 days after seasonal influenza vaccination during the 1996-2017 seasons.
Conclusions: The AIV presents better performance against the A(H3N2) subtype in the elderly whereas the NAIV induces a better response against A(H1N1)pdm09 in the same group.
Keywords: Vaccines; adjuvanted Vaccines; influenza A.
. 2020 Nov 25;8(4):E704.
doi: 10.3390/vaccines8040704.
Adjuvanted Influenza Vaccines Elicits Higher Antibody Responses against the A(H3N2) Subtype than Non-Adjuvanted Vaccines
Laura S?nchez de Prada[SUP] 1 [/SUP], Iv?n Sanz Mu?oz[SUP] 2 [/SUP], Javier Castrodeza Sanz[SUP] 1 [/SUP], Ra?l Ortiz de Lejarazu Leonardo[SUP] 2 [/SUP], Jos? Mar?a Eiros Bouza[SUP] 2 3 [/SUP]
Affiliations
- PMID: 33255600
- DOI: 10.3390/vaccines8040704
Abstract
Background: vaccination is the best approach to prevent influenza infections so far. Serological studies on the effect of different vaccine types are important to address vaccination campaigns and protect our population. In our study, we compared the serological response against influenza A subtypes using the non-adjuvanted influenza vaccine (NAIV) in adults and the elderly and the adjuvanted influenza vaccine (AIV) in the elderly.
Methods: We performed a retrospective analysis by hemagglutination inhibition assay (HI) of serum samples right before and 28 days after seasonal influenza vaccination during the 1996-2017 seasons.
Conclusions: The AIV presents better performance against the A(H3N2) subtype in the elderly whereas the NAIV induces a better response against A(H1N1)pdm09 in the same group.
Keywords: Vaccines; adjuvanted Vaccines; influenza A.